SciBase Holding AB (publ) (SCIB.ST) News
Follow SciBase Holding AB (publ) (SCIB.ST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BRIEF — Scibase Says EIS Technology Primary Endpoint In NIH Study
Oct 15 (Reuters) — SciBase Holding AB (publ): Scibase's Electrical Impedance Spectroscopy (Eis) Technology Selected As Primary Endpoint In National Institute Of Health (Nih) Skin Barrier Study Source text:... Further com
NEWS | Oct 15, 2026, 08:32 AM UTC
L
NIH selects SciBase's EIS technology as primary endpoint in skin barrier study
SciBase’s Nevisense device was selected as the primary endpoint measurement tool for the NIH-led THREAT study of environmental exposure effects on skin. The planned study involves 80 healthy volunteers in collaboration w
NEWS | Oct 15, 2026, 06:08 AM UTC
L
SciBase wins first US payer coverage as Highmark backs Nevisense policy
SciBase secured its first US private payer coverage for Nevisense after Highmark Blue Cross Blue Shield issued a positive medical policy. The decision shifts eligible use from mostly cash-pay to reimbursed care, easing a
NEWS | Oct 14, 2026, 07:06 AM UTC
L
BRIEF — SciBase's Nevisense Gets First Positive Medical Policy
Oct 14 (Reuters) — SciBase Holding AB (publ): Nevisense Receives First Positive Medical Policy From Highmark Blue Cross Blue Shield In U.s. Source text:... Further company coverage: SCIB.ST (Gdansk Newsroom) ((gdansk.new
NEWS | Oct 14, 2026, 07:05 AM UTC